When is cytotoxic chemotherapy indicated for the treatment of myelodysplastic syndrome (MDS)?

Updated: Apr 10, 2020
  • Author: Emmanuel C Besa, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print

Cytotoxic chemotherapy is used in patients with MDS with increasing myeloblasts and those who have progressed to acute leukemia. The usual combination treatment is a cytarabine-anthracycline combination, which yields a response rate of 30-40% (high complication rate and morbidity in elderly patients).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!